In this episode of The Swine Health Blackbelt Podcast, Dr. Fernando Leite from Boehringer Ingelheim explores how different PCV2 genotypes impact immunity in swine. He shares findings from a recent trial comparing homologous and heterologous vaccination strategies under real-world challenge conditions with PRRSV. Learn how genotype 2d immunized pigs performed and why this may offer superior protection."The PCV2d genotype today is the most prevalent genotype, and it has been for some years now."𝗠𝗲𝗲𝘁 𝘁𝗵𝗲 𝗴𝘂𝗲𝘀𝘁: Dr. Fernando Leite earned his DVM in Brazil and completed his M.S. at Iowa State University and Ph.D. at the University of Minnesota, focusing on swine infectious diseases. He currently serves as Associate Director of Technical Marketing for Swine at Boehringer Ingelheim.Click here to read the full research article!Liked this one? Don’t stop now — Here’s what we think you’ll love!Dr. Pablo Piñeyro: PCV4 & Co-infections | Ep. 139Dr. Reid Philips: PRRS Vaccine Efficacy | Ep. 143Dr. Tyler Bauman: PRRS Control in Grow-Finish Pigs | Ep. 156What you will learn:(00:00) Highlight(01:16) Introduction(03:05) PCV2d genotype prevalence(04:11) Immunization efficacy comparison(05:37) Homologous vs heterologous use(06:35) Comparing efficacy results(09:30) Field application strategies(12:03) Closing thoughtsThe Swine Health Blackbelt Podcast is trusted and supported by innovative companies like:* Boehringer Ingelheim- Farm Health Guardian𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺.Website: The Swine Health Blackbelt PodcastInstagram: Swine CampusLinkedIn: Swine Campus

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related